Research Article

Ethical Issues in Pharmacologic Research in Women Undergoing Pregnancy Termination: A Systemic Review and Survey of Researchers

Table 1

Studies where exogenous drug was administered and sampled from women and their abortus prior to pregnancy termination.

ReferenceYearCountryXenobiotic

[3]2005Hong KongRosiglitazone
[4]2002Hong KongNaproxen
[5]2002Israel(15S)-15 Methyl PG
F2alpha
[6]2002Belgium ans UK and MadridCefoxitin,
moxalactam and
ceftazidime
[7]1999Belgium and UKGlucose
[8]1999FranceDiclofenac
[9]1998Belgium and UKFentanyl
[10]1996Belgium and UKDiazepam
[11]1993Belgium and UKFentanyl
[12]1993GermanyThyroxine
[13]1983CanadaEthanol
[14]1980FinlandOxazepam
[15]1978CzechSodium salicylate
[16]1977USACefazolin
[17]1977USAAmikacin
[18]1997UKInulin
[19]1977USATobramycin
[20]1999USAHeroin
[21]1975SingaporeThiamphenicol

GA: gestational age; IRB: ethics approval obtained; Consent: clearly declared consent obtained; Mat: maternal blood samples; Fetal: fetal blood samples obtained; Amniotic: amniotic/celomic samples obtained; FT: fetal tissue collected and sampled.